Skip to main content
Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
11.02
+0.33 (3.09%)
At close: Mar 9, 2026, 4:00 PM EDT
11.54
+0.52 (4.71%)
After-hours: Mar 9, 2026, 4:43 PM EDT

Tenax Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
6
Market Cap
447.09M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024---
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Niagen Bioscience 129.42M
Autolus Therapeutics 51.13M
Assembly Biosciences 37.19M
Lineage Cell Therapeutics 14.56M
Upstream Bio 2.80M
4D Molecular Therapeutics 120.00K
vTv Therapeutics 17.00K
Revenue Rankings

TENX News

More News